s6y
Company name or ticker
Search
Foghorn Therapeutics Inc.
3
BIOTECHNOLOGY VALUE FUND L P: Initial statement of beneficial ownership of securities
Filed
Monday, October 5, 2026
Period
Oct 1, 2026
Accession number
0000921895-26-002730
Documents
OWNERSHIP DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header